Application 213369
- Type
- ANDA
- Sponsor
- APOTEX
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OXCARBAZEPINE | OXCARBAZEPINE | TABLET, EXTENDED RELEASE;ORAL | 150MG | No | No |
| 002 | OXCARBAZEPINE | OXCARBAZEPINE | TABLET, EXTENDED RELEASE;ORAL | 300MG | No | No |
| 003 | OXCARBAZEPINE | OXCARBAZEPINE | TABLET, EXTENDED RELEASE;ORAL | 600MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213369-001 | OXCARBAZEPINE | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | |
| A213369-002 | OXCARBAZEPINE | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | |
| A213369-003 | OXCARBAZEPINE | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A213369-001 | AB |
| A213369-002 | AB |
| A213369-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | 2023-07-13 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | 2023-07-13 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-07-13 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | 2023-07-13 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A213369-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A213369-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A213369-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A213369-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A213369-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A213369-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A213369-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A213369-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A213369-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213369-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213369-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213369-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A213369-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A213369-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A213369-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213369-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213369-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213369-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213369-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213369-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213369-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213369-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213369-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213369-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213369-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213369-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213369-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213369-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213369-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213369-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213369-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213369-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213369-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A213369-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A213369-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A213369-003 | AB | 1 | d06236e962d9… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213369-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213369-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213369-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxcarbazepine | OXCARBAZEPINE | NCS HealthCare of KY, LLC dba Vangard Labs | a14b5756-4fd1-4ba7-bc23-e1fa9212a148 | 2026-05-18 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Coupler LLC | 512ab25c-ea79-1e59-e063-6294a90ae9a0 | 2026-05-06 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Umedica Laboratories USA Inc. | e46d4654-76bc-4c33-ac2b-e89ae11b7697 | 2026-05-05 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Coupler LLC | 51008af2-39ac-546c-e063-6294a90a758f | 2026-05-04 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Major Pharmaceuticals | 567c0777-9bc5-45a9-ba25-959dd76d0e05 | 2026-04-30 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Coupler LLC | 50873ef7-3deb-7386-e063-6394a90a9c19 | 2026-04-28 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Bryant Ranch Prepack | 87f53c04-075c-4d09-925a-0faeaa14f3f9 | 2026-04-23 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Breckenridge Pharmaceutical, Inc. | 54fb494e-bce4-442d-954a-757f9851e81e | 2026-04-13 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Bryant Ranch Prepack | 148b90ba-236a-47cc-b171-22dd7f8f8e0a | 2026-03-20 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | NorthStar RxLLC | 20d826cd-fa4a-4570-9e10-9d7d10fb725b | 2026-03-17 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Advagen Pharma Limited | b0bc10f0-7d1b-4adc-bc59-c48dab58ee5a | 2026-02-24 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Advagen Pharma Ltd. | ab4c1f36-82fa-40a2-a31a-227875d0f382 | 2026-02-04 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | REMEDYREPACK INC. | 244f9a68-5ab4-46b8-a01f-538572fd3c5f | 2026-02-03 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | REMEDYREPACK INC. | 6d2a6cac-f16b-4e6c-8f75-3afffb0a0f3b | 2026-02-03 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Camber Pharmaceuticals, Inc. | fe49a773-562c-4da6-96b7-bba52f4d61e2 | 2026-01-30 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Advagen Pharma Ltd | 4ef6a941-a017-40f2-a50a-ab66c43b3347 | 2026-01-13 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Chartwell RX, LLC | c2affa00-1d57-4d85-8db3-745191b4714d | 2026-01-08 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Coupler LLC | 47b92168-6832-1e0b-e063-6394a90a079a | 2026-01-06 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Chartwell Governmental & Specialty RX, LLC. | e74bb389-8426-4ffc-a14b-a5990de6d0d4 | 2025-12-26 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Trileptal | OXCARBAZEPINE | Novartis Pharmaceuticals Corporation | 4c5c86c8-ab7f-4fcf-bc1b-5a0b1fd0691b | 2025-12-16 | Warnings, Adverse reactions | OXCARBAZEPINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 75163 | ORIG | 2023-08-21 |